Edwards Lifesciences
Clinical trials sponsored by Edwards Lifesciences, explained in plain language.
-
New heart valve repair shows promise for patients too sick for surgery
Disease control CompletedThis study tested a new device called PASCAL to repair leaky tricuspid valves in 65 people with severe symptoms. The goal was to see if it's safe and works well. Participants had the device placed through a tube in a vein, avoiding open-heart surgery.
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New heart valve offers hope for High-Risk chinese patients
Disease control CompletedThis study tested the safety and effectiveness of the SAPIEN 3 heart valve in 58 Chinese patients with severe aortic stenosis who were too high-risk for open-heart surgery. The valve was implanted using a less invasive procedure called TAVI. Researchers tracked how many patients …
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Smart alerts may help surgeons protect kidneys during operations
Knowledge-focused CompletedThis study tested whether smart alerts from a monitoring system help doctors follow a blood pressure management plan during major surgery. The goal was to see if this could reduce kidney injury after surgery. 296 adults having elective noncardiac surgery took part. The study comp…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Knowledge-focused
Last updated May 01, 2026 20:57 UTC
-
New blood pressure monitor tested in surgery
Knowledge-focused CompletedThis study tested a new blood pressure monitor called ClearSight NextGen in 35 adults having surgery. The goal was to collect blood pressure data to help improve the device. Participants wore the new monitor along with standard monitors to compare readings.
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC